Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis

Background: Targeted therapy for cancer is becoming more frequent as the understanding of the molecular pathogenesis increases. Molecular testing must be done to use targeted therapy. Unfortunately, the testing turnaround time can delay the initiation of targeted therapy. Objective: To investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Silas, Ubong, Blüher, Maximilian, Bosworth Smith, Antonia, Saunders, Rhodri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306161/
https://www.ncbi.nlm.nih.gov/pubmed/37389301
http://dx.doi.org/10.36469/001c.77686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306161/
https://www.ncbi.nlm.nih.gov/pubmed/37389301
http://dx.doi.org/10.36469/001c.77686

Ejemplares similares